An analysis of invasive Escherichia coli isolates collected from 26 countries found that more than one-third were multidrug-resistant (MDR), researchers reported today in Clinical Infectious Diseases.
The study, by researchers with drugmaker Johnson & Johnson, analyzed more than 10,000 E coli isolates collected from patients with bloodstream infections from 2011 through 2023. The aim of the study was to evaluate the antibiotic resistance, sequence type (ST), and O-serotype distribution of extraintestinal pathogenic E coli (ExPEC), a pathogen that can infect sites outside the intestines and cause invasive E coli disease, or IED, which includes life-threatening conditions like sepsis.
“Increasing antimicrobial resistance rates and the emergence of multidrug-resistant (MDR) E. coli strains represent a major challenge in the treatment of IED,” the study authors wrote. “In particular, resistance to carbapenems, third-generation cephalosporins, aminoglycosides, or fluoroquinolones is an obstacle to successful treatment.”
34% of E coli isolates labeled as MDR
Of the 10,098 ExPEC isolates collected, 34% were labeled as MDR, but there was a wide variation between countries. India had the highest MDR rate (83.3%), followed by Mexico (76.6%) and China (69.4%), while the Netherlands (12.1%), New Zealand (11.6%), and Sweden (10.6%) had the lowest MDR rates. Countries with lower income levels tended to have higher rates of MDR E coli.
Overall, serotypes O25, O2, O6, and O1 were the most prevalent. Among the MDR isolates, O25 was the most prevalent in all countries (ranging from 11.3% in China to 56.2% in Mexico). ST131, a globally dominant clone and important cause of urinary tract and bloodstream infections worldwide, accounted for 33% of all MDR isolates.
“Our findings stress the importance of epidemiological studies to monitor the prevalence of high-risk ExPEC clones and highlight the need for ongoing research into novel preventive and therapeutic strategies, including vaccines, to reduce the burden of bacterial disease and limit the spread of antimicrobial resistance,” the authors concluded.